Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to Fulcrum's Therapeutics Second Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions].
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | RA Capital Management Peter Kolchinsky | 11,609,704 | $71,980,165 | 0.95% | |
2. | Suvretta Capital Management Aaron Cowen | 2,541,046 | $15,754,485 | -11% | 0.57% |
3. | Citadel Investment Group Ken Griffin | 1,777,112 | $11,018,095 | +35% | 0% |
4. | 1,500,000 | $9,300,000 | +50% | 0.75% | |
5. | BioImpact Capital Mpm Capital | 1,444,851 | $8,958,076 | +28% | 1.39% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$11.35 | 43,360 | 43,360 | 2024-03-04 | Filing | ||
$13.00 | 1,923,076 | Large Shareholder | 11,609,704 | 2023-01-20 | Filing | |
$7.80 | 58,369 | Large Shareholder | 9,686,628 | 2023-01-04 | Filing | |
$7.03 | 122,334 | Large Shareholder | 9,628,259 | 2023-01-04 | Filing | |
$5.99 | 4,089 | Large Shareholder | 9,505,925 | 2022-12-27 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$7.76 | 236 | 11,571 | 2024-05-07 | Filing | ||
$11.72 | 4,884 | 11,807 | 2024-03-08 | Filing | ||
$3.31 | 210 | 15,992 | 2023-05-10 | Filing | ||
$15.00 | 6,766 | Officer, Director | 499,864 | 2023-01-13 | Filing | |
$8.09 | 71,435 | Director | 506,630 | 2022-06-07 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 5,684,615 | $38,371,151 | 0% | |
2. | 5,469,956 | $36,922,203 | 0.57% | |
3. | 3,473,934 | $23,449,054 | 1.53% | |
4. | 2,519,984 | $17,009,892 | 0% | |
5. | 2,343,154 | $15,816,290 | 6.42% |